Core Capital Management & Research, inc.’s Organon & Co OGN Stock Holding History

Core Capital Management & Research, inc.’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$179	Buy	+13	New	+$155	﹤0.01%	212

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Core Capital Management & Research, inc.'s OGN Position: Q2 2026 in Review

Core Capital Management & Research, inc. opened a new position in Organon & Co (OGN) in Q2 2026: 13 shares worth $179. The stake represents ﹤0.01% of the portfolio and ranks #212 among its holdings.

634 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Core Capital Management & Research, inc. held 13 shares of Organon & Co worth $179 as of Q2 2026.
Organon & Co was a new Core Capital Management & Research, inc. position in Q2 2026.
Organon & Co made up ﹤0.01% of Core Capital Management & Research, inc.'s portfolio in Q2 2026, its #212 holding.
634 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Core Capital Management & Research, inc.'s 13F filing for Q2 2026, filed 9 Sep 2026.